Facebook
Twitter
Telegram
Report an ErrorAdverum Biotechnologies Financial Statements 2011-2024 | ADVM
Annual Financial Statements Adverum Biotechnologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
178 M | 77.4 M | 173 M | 790 M | 666 M | 186 M | 347 M | 103 M | 155 M | 903 M | - | - | - |
Shares |
101 M | 99.3 M | 98 M | 64.1 M | 64.1 M | 61.4 M | 43.7 M | 36.2 M | 25.9 M | 22.8 M | - | - | - |
Historical Prices |
1.77 | 0.78 | 1.76 | 10.8 | 11.5 | 3.15 | 3.5 | 2.9 | 9.52 | 54 | - | - | - |
Net Income |
-117 M | -155 M | -146 M | -118 M | -64.5 M | -72.6 M | -56.1 M | -114 M | -47.5 M | -25.4 M | -5.28 M | -1.81 M | - |
Revenue |
3.6 M | - | 7.5 M | - | 250 K | 1.61 M | 1.85 M | 1.46 M | 2.32 M | 572 K | 480 K | 30 K | - |
Cost of Revenue |
- | - | - | - | - | 100 K | 500 K | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 2.32 M | 572 K | 480 K | 30 K | - |
Operating Income |
-124 M | -157 M | -146 M | -118 M | -68.5 M | -78.1 M | -58.8 M | -115 M | -47.8 M | -24.4 M | -3.45 M | -1.82 M | - |
Interest Expense |
- | - | - | - | - | 4.2 M | 2.7 M | 762 K | 370 K | 18 K | 73 K | 8 K | - |
EBITDA |
-118 M | -151 M | -141 M | -114 M | -67 M | -71.3 M | -56.8 M | -53 M | -44.4 M | -24.2 M | -3.43 M | -1.82 M | - |
Operating Expenses |
128 M | 157 M | 154 M | 118 M | 68.8 M | 74.7 M | 60.7 M | 56 M | 47.6 M | 25 M | 3.93 M | 1.85 M | - |
General and Administrative Expenses |
49.9 M | 57.9 M | 64.4 M | 44.6 M | 28.4 M | 24.6 M | 20.9 M | 24.4 M | 22.1 M | 8 M | 1.78 M | 536 K | - |
All numbers in USD currency
Quarterly Income Statement Adverum Biotechnologies
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
16.5 M | 101 M | 101 M | 10 M | - | 99.5 M | 99 M | 98.6 M | 98.4 M | 98.1 M | 98 M | 97.8 M | 97.5 M | 88.9 M | 80.2 M | 73.8 M | 67.3 M | 64.5 M | 63.7 M | 63.1 M | 63 M | 62.5 M | 62.4 M | 57.4 M | 49 M | 43.4 M | 43 M | 42.1 M | 41.8 M | 41.4 M | 35 M | 27.1 M | 25.9 M | 25.7 M | 25.6 M | 24.9 M | 22.8 M | 16.4 M | 3.67 M | 3.67 M | 3.67 M | 3.67 M | 3.67 M | - | - | - | - | - | - | - | - | - |
Net Income |
-24.8 M | -32.9 M | -31.5 M | -29.1 M | - | -40.1 M | -43.8 M | -37.9 M | - | -38.4 M | -44.3 M | -28.4 M | - | -27.8 M | -29.2 M | -22.9 M | - | -16.1 M | -15 M | -14.5 M | -15.7 M | -21 M | -18.8 M | -17.2 M | -14.8 M | -13.8 M | -11.4 M | -16.1 M | -22.4 M | -14.3 M | -61.7 M | -15.4 M | -14.1 M | -14.1 M | -9.77 M | -9.51 M | -10.4 M | -8.26 M | -5.09 M | -1.66 M | -3.69 M | -813 K | -721 K | -49 K | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 3.6 M | - | - | - | - | 7.5 M | - | - | 7.5 M | - | - | - | - | - | 250 K | - | - | 70 K | 833 K | 493 K | 216 K | 461 K | 463 K | 463 K | 462 K | 488 K | 395 K | 307 K | 265 K | 960 K | 953 K | 203 K | 203 K | 203 K | 204 K | 135 K | 30 K | - | 30 K | 150 K | 300 K | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-26.8 M | -34.5 M | -33.1 M | -30.2 M | - | -41 M | -44 M | -38.1 M | - | -38.5 M | -44.5 M | -28.6 M | - | -28 M | -29.8 M | -23.8 M | - | -17.1 M | -16.1 M | -15.7 M | - | -23.5 M | -19.9 M | -17.9 M | - | -14.6 M | -12.1 M | -16.6 M | - | -14.5 M | -61.9 M | -15.5 M | - | -14.2 M | -9.88 M | -9.56 M | - | -7.94 M | -4.45 M | -1.61 M | - | -778 K | -705 K | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.15 M | 1.22 M | - | 1.26 M | 1.09 M | 746 K | - | 742 K | 663 K | 489 K | - | 206 K | 222 K | 116 K | - | 117 K | 116 K | 52 K | - | 18 K | 4 K | 14 K | - | 28 K | 20 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-25.8 M | - | - | -28.6 M | - | -36.2 M | -41 M | -36.7 M | - | -35.2 M | -42.2 M | -27.5 M | - | -26.8 M | -28.5 M | -23.2 M | - | -16.7 M | -15.7 M | -15.3 M | - | -23.1 M | -19.4 M | -17.5 M | - | -14.1 M | -11.5 M | -16.1 M | - | -14.1 M | -61.6 M | -15.2 M | - | -14 M | -9.74 M | -9.44 M | - | -7.89 M | -4.43 M | -1.6 M | - | -771 K | -698 K | - | - | - | - | - | - | - | - | - |
Operating Expenses |
26.8 M | 34.5 M | 33.1 M | 33.8 M | - | 41 M | 44 M | 38.1 M | - | 38.5 M | 44.5 M | 36.1 M | - | 28 M | 29.8 M | 23.8 M | - | 17.3 M | 16.1 M | 15.7 M | 16.8 M | 24.3 M | 20.4 M | 18.2 M | 16.1 M | 15 M | 12.6 M | 17 M | 23.9 M | 14.9 M | 62.2 M | 15.8 M | 15.1 M | 15.2 M | 10.1 M | 9.76 M | 10.6 M | 8.14 M | 4.59 M | 1.64 M | 1.93 M | 808 K | 855 K | 342 K | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
11.4 M | 13.8 M | 12.5 M | 12.8 M | - | 17.2 M | 13.8 M | 15.2 M | - | 14.5 M | 21.9 M | 16.2 M | - | 11.4 M | 10.6 M | 9.04 M | - | 7.39 M | 7.13 M | 5.58 M | - | 4.83 M | 9.18 M | 5.37 M | - | 4.76 M | 4.06 M | 7.99 M | - | 6.15 M | 5.11 M | 8.32 M | - | 7.63 M | 4.96 M | 4.14 M | - | 2.4 M | 1.49 M | 726 K | - | 258 K | 194 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency